I'ROM GROUP CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,784 JPY | 0.00% |
|
+0.11% | +38.63% |
| 2023 | I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2022 | Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| I'ROM GROUP CO., LTD. | Medical & Diagnostic Laboratories | 0.00% | +0.11% | +38.63% | +46.35% | +70.44% | 215M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 2372 Stock
- Charts I'rom Group Co., Ltd.
- Comparison Chart
